NCT07469202 2026-03-13
CYTALUX Dose Extension Study
On Target Laboratories, LLC
Phase 4 Not yet recruiting
On Target Laboratories, LLC
Mayo Clinic
Fundacion Clinic per a la Recerca Biomédica
International Agency for Research on Cancer
Peking University People's Hospital
GlaxoSmithKline
GlaxoSmithKline
Istanbul University
Rwanda Biomedical Centre